March 2024
1. DUARTE-SILVA M, Parra RS, Feitosa MR, Nardini V, et al
   Leukocyte Dysfunction and reduced CTLA-4 Expression are Associated with Perianal Crohn's Disease.
   Clin Exp Immunol. 2024 Mar 22:uxae027. doi: 10.1093.
   

   >> Share

   
   January 2024
2. MORET-TATAY I, Nos P, Iborra M, Rausell F, et al
   Catalase inhibition can modulate the ability of peripheral blood T cells to undergo apoptosis in Crohn's disease.
   Clin Exp Immunol. 2024 Jan 22:uxad134. doi: 10.1093.
   

   >> Share

   
   August 2023
3. DEVAN J, Nosi V, Spagnuolo J, Chancellor A, et al
   Surface protein and functional analyses identify CD4+CD39+ TCR alphabeta+ and activated TCR Vdelta1+ cells with distinct pro-inflammatory functions in Crohn's Disease lesions.
   Clin Exp Immunol. 2023 Aug 16:uxad098. doi: 10.1093.
   

   >> Share

   
   
4. SEIDELIN JB, Jensen S, Hansen M, Bronze MRC, et al
   IAPs and RIPK1 mediate LPS-induced cytokine production in healthy subjects and Crohn's disease.
   Clin Exp Immunol. 2023 Aug 16:uxad092. doi: 10.1093.
   

   >> Share

   
   
5. LUTTER L, Ter Linde JJM, Brand EC, Hoytema van Konijnenburg DP, et al
   Compartment-driven imprinting of intestinal CD4 T cells in inflammatory bowel disease and homeostasis.
   Clin Exp Immunol. 2023 Aug 11:uxad095. doi: 10.1093.
   

   >> Share

   
   September 2022
6. HU M, Chen Z, Liao Y, Wu J, et al
   Clinical value of the expression levels of protein tyrosine phosphatase non-receptor type 22.6 mRNA in peripheral blood mononuclear cells in Crohn's disease.
   Clin Exp Immunol. 2022;209:311-315.
   

   >> Share

   
   June 2022
7. MA K, Que W, Hu X, Guo WZ, et al
   Combinations of anti-GITR antibody and CD28 superagonist ameliorated dextran sodium sulfate-induced mouse colitis.
   Clin Exp Immunol. 2022;208:340-350.
   

   >> Share

   
   
8. SHARIFINEJAD N, Zaki-Dizaji M, Sepahvandi R, Fayyaz F, et al
   The clinical, molecular, and therapeutic features of patients with IL10/IL10R deficiency: a systematic review.
   Clin Exp Immunol. 2022;208:281-291.
   

   >> Share

   
   May 2021
9. QIAN K, Yuan L, Wang S, Kuang Y, et al
   Inhibitor of apoptosis stimulating p53 protein (iASPP) protects against inflammatory bowel disease (IBD) in mice models by inhibiting the NF-kappaB signaling.
   Clin Exp Immunol. 2021 May 3. doi: 10.1111/cei.13613.
   

   >> Share

   
   February 2021
10. LAN X, Liu F, Ma J, Chang Y, et al
    Leukocyte immunoglobulin-like receptor A3 is increased in IBD patients and functions as an anti-inflammatory modulator.
    Clin Exp Immunol. 2021;203:286-303.
    

    >> Share

    
    June 2020
11. SHAMRIZ O, Simon AJ, Lev A, Megged O, et al
    Exogenous interleukin-2 can rescue in-vitro T cell activation and proliferation in patients with a novel capping protein regulator and myosin 1 linker 2 mutation.
    Clin Exp Immunol. 2020;200:215-227.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share